4.7 Article

DISC1-binding proteins in neural development, signalling and schizophrenia

Journal

NEUROPHARMACOLOGY
Volume 62, Issue 3, Pages 1230-1241

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2010.12.027

Keywords

DISC1; Schizophrenia; Neurodevelopment; Signalling; Synapse; Association studies

Funding

  1. Wellcome Trust [088179/A/09/Z]
  2. Wellcome Trust [088179/A/09/Z] Funding Source: Wellcome Trust
  3. Medical Research Council [G0100266] Funding Source: researchfish
  4. MRC [G0100266] Funding Source: UKRI

Ask authors/readers for more resources

In the decade since Disrupted in Schizophrenia 1 (DISC1) was first identified it has become one of the most convincing risk genes for major mental illness. As a multi-functional scaffold protein, DISC1 has multiple identified protein interaction partners that highlight pathologically relevant molecular pathways with potential for pharmaceutical intervention. Amongst these are proteins involved in neuronal migration (e.g. APP, Dixdc1, LIS1, NDE1, NDEL1), neural progenitor proliferation (GSK3 beta), neurosignalling (Girdin, GSK3 beta, PDE4) and synaptic function (Kal7, TNIK). Furthermore, emerging evidence of genetic association (NDEL1, PCM1, PDE4B) and copy number variation (NDE1) implicate several DISC1-binding partners as risk factors for schizophrenia in their own right. Thus, a picture begins to emerge of DISC1 as a key hub for multiple critical developmental pathways within the brain, disruption of which can lead to a variety of psychiatric illness phenotypes. This article is part of a Special Issue entitled 'Schizophrenia'. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available